NODE NEGATIVE BREAST CANCER

Clinical trials for NODE NEGATIVE BREAST CANCER explained in plain language.

Never miss a new study

Get alerted when new NODE NEGATIVE BREAST CANCER trials appear

Sign up with your email to follow new studies for NODE NEGATIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New drug combo aims to stop early breast cancer from coming back

Disease control Recruiting now

This study is testing whether a combination of two targeted drugs (pertuzumab and trastuzumab) plus hormone therapy, given after surgery, can help prevent cancer from returning in people with early-stage, hormone-positive, HER2-positive breast cancer. About 375 participants will …

Matched conditions: NODE NEGATIVE BREAST CANCER

Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

NODE NEGATIVE BREAST CANCER

Get alerted when new NODE NEGATIVE BREAST CANCER trials appear

New drug combo aims to stop early breast cancer from coming back